Duloxetine HCL DR Capsules
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D219R0052 | Duloxetine HCL DR Capsules | |
| Synopsis | ||
|
Duloxetine HCL DR Capsules .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D219R0052 | Duloxetine HCL DR Capsules | |
| Synopsis | ||
|
Modification P00001 to Invoke Option Year 1 for the Duloxetine HCL DR National Contract SPE2D2-20-D-0098. Amendment 0003 SPE2D219R0052 dated 02/11/2020 to add Delayed Release (DR) to the drug name for line items 0004 and 0005 on the Schedule of Supply page 2 of 76 of the solicitation. See attached amendment 0003 and updated Schedule of Supply attachment. Amendment 0002 SPE2D219R0052 dated 02/10/2020 revising closing date to reflect February 18, 2020 at 3:00 PM EST I/L/O February 11, 2020 at 3:00 PM EST. Amendment 0001 SPE2D219R0052 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY (DLA) | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D219R0052 | Duloxetine HCL DR Capsules | |
| Synopsis | ||
|
Duloxetine HCL DR Capsules .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY (DLA) | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D219R0052 | Duloxetine HCL DR Capsules | |
| Synopsis | ||
|
Modification P00001 to Invoke Option Year 1 for the Duloxetine HCL DR National Contract SPE2D2-20-D-0098. Amendment 0003 SPE2D219R0052 dated 02/11/2020 to add Delayed Release (DR) to the drug name for line items 0004 and 0005 on the Schedule of Supply page 2 of 76 of the solicitation. See attached amendment 0003 and updated Schedule of Supply attachment. Amendment 0002 SPE2D219R0052 dated 02/10/2020 revising closing date to reflect February 18, 2020 at 3:00 PM EST I/L/O February 11, 2020 at 3:00 PM EST. Amendment 0001 SPE2D219R0052 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY (DLA) | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D219R0052 | Duloxetine HCL DR Capsules | DEFENSE LOGISTICS AGENCY (DLA) |
| Synopsis | ||
|
Modification P00001 to Invoke Option Year 1 for the Duloxetine HCL DR National Contract SPE2D2-20-D-0098. Amendment 0003 SPE2D219R0052 dated 02/11/2020 to add Delayed Release (DR) to the drug name for line items 0004 and 0005 on the Schedule of Supply page 2 of 76 of the solicitation. See attached amendment 0003 and updated Schedule of Supply attachment. Amendment 0002 SPE2D219R0052 dated 02/10/2020 revising closing date to reflect February 18, 2020 at 3:00 PM EST I/L/O February 11, 2020 at 3:00 PM EST. Amendment 0001 SPE2D219R0052 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY (DLA) | DEPT OF DEFENSE | Combined Synopsis/Solicitation |
